Evidence map›Paper›PMID 35661841›Full record

ArticleBreast (Edinburgh, Scotland)2022

Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study.

Martha Duraes, Gauthier Rathat, Sophie Bringer-Deutsch, Noémie Ranisavljevic, Sophie Brouillet, Christine Defez-Fougeron, Claire Duflos

Open access · goldAbstract read
In one paragraph

Article in Breast (Edinburgh, Scotland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Martha DuraesDepartment of Gynecological and Breast Surgery, Montpellier University Hospital, Montpellier, France. Electronic address: m-duraes@chu-montpellier.fr.
Gauthier RathatDepartment of Gynecological and Breast Surgery, Montpellier University Hospital, Montpellier, France.
Sophie Bringer-DeutschDepartment of Obstetrics, Gynecology and Reproductive Medicine, Montpellier University Hospital, Montpellier, France.
Noémie RanisavljevicDepartment of Obstetrics, Gynecology and Reproductive Medicine, Montpellier University Hospital, Montpellier, France.
Sophie BrouilletDepartment of Reproductive Biology, Montpellier University Hospital, Montpellier, France.
Christine Defez-FougeronClinical Research and Epidemiology Unit, Montpellier University Hospital, Montpellier, France.
Claire DuflosClinical Research and Epidemiology Unit, Montpellier University Hospital, Montpellier, France.
Université de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApproximately 7% of breast cancers are diagnosed in women under 40. Question of subsequent fertility has become fundamental. We aimed to evaluate the rate of fertility preservation (FP) by oocyte retrieval (OR) after ovarian stimulation in patients of childbearing age, managed for breast cancer with adjuvant chemotherapy in France, reuse rate of frozen gametes and live births rate (LBR) after treatment.

methodsWe included 15,774 women between 18 and 40 years old, managed by surgery and adjuvant chemotherapy for breast cancer, between January 2011 and December 2020 from a French health registry. Patients with OR after breast surgery and before chemotherapy were considered as FP group; those with no OR as no FP group. To compare LBR with French population independently of age, we calculated Standardized Incidence Rates (SIR) of live births using indirect standardization method.

resultsFP rate increased gradually since 2011, reaching 17% in 2019. A decrease in use was observed in 2020 (13,9%). Among patients with at least 2 years of follow-up, gamete reuse rate was 5,6%. Births after cancer were mostly from spontaneous pregnancies. Among patients with at least 3 years of follow-up, LBR was 19,6% in FP group, 3,9% in second group. SIR of live births was of 1,05 (95% CI = 0.91-1.19) and 0.33 (95% CI = 0.30-0.36) in FP and no FP group respectively.

conclusionOncofertility activity increased until 2019 in France, reaching 17%. Gamete reuse rate was low. Births resulted mainly from spontaneous pregnancies. SIR of live births was lower in no FP group.

Indexed as

Breast NeoplasmsFertility PreservationCohort StudiesCryopreservationFemaleHumansOocyte RetrievalPregnancyRetrospective StudiesAdjuvant chemotherapyBreast cancerLive birthOncofertilityOocyte retrieval

Identifiers

PMID35661841
PMCPMC9163100
OpenAlexW4281644302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.